Cargando…
Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
This network meta-analysis compared the short-term and long-term efficacies of first-line chemotherapy regimens in patients with advanced colorectal cancer (CRC). The 10 regimens included folinic acid + 5-fluorouracil + oxaliplatin (FOLFOX), folinic acid + 5-fluorouracil + irinotecan (FOLFIRI), foli...
Autores principales: | Wu, Dong-Mei, Wang, Yong-Jian, Fan, Shao-Hua, Zhuang, Juan, Zhang, Zi-Feng, Shan, Qun, Han, Xin-Rui, Wen, Xin, Li, Meng-Qiu, Hu, Bin, Sun, Chun-Hui, Bao, Ya-Xing, Xiao, Hai-Juan, Yang, Lin, Lu, Jun, Zheng, Yuan-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725053/ https://www.ncbi.nlm.nih.gov/pubmed/29246011 http://dx.doi.org/10.18632/oncotarget.22177 |
Ejemplares similares
-
Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis
por: Lyu, Wen-Wen, et al.
Publicado: (2016) -
Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
por: Li, Mu-Xing, et al.
Publicado: (2016) -
Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis
por: Citterio, Chiara, et al.
Publicado: (2018) -
Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis
por: Xu, Linchun, et al.
Publicado: (2023) -
Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)